B6Monitoring for advanced disease in the UTT era: trends in CD4 count testing volumes among patients presenting for HIV care in South AfricaE-posterViral load and CD4 measurement
B6Viral load in adults switching to DTG-BASED first-line ART in Malawi and ZambiaE-posterViral load and CD4 measurement
B59No age-related difference in dolutegravir metabolic glucuronidation ratio in children between 3 months and 18 years old in the ODYSSEY trialE-posterPharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations
B59Expected impact of malnutrition on first-line antiretroviral drug exposure in a global population of children in countries with highest child mortality: a quantitative modeling and simulation studyE-posterPharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations
B59Pharmacokinetics and safety of dispersible and immediate release FDC abacavir/dolutegravir/lamivudine in children with HIV weighing '¥14 kg: preliminary results from IMPAACT 2019E-posterPharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations
B59Pharmacokinetics, safety and acceptability of a single dose of abacavir/lamivudine/lopinavir/ritonavir (4-in-1) fixed-dose granule formulation in neonates: PETITE studyE-posterPharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations
B58Relationship of the haematological profile with the viral load and clinical staging of HIV infected children at the Obafemi Awolowo university teaching hospitals complex (OAUTHC), Ile-Ife, Osun state, NigeriaE-posterDiagnosis of HIV disease in paediatric and adolescent populations
B58Plasma IP-10 concentrations show no correlation with HIV infection in children attending hospitals in Blantyre and Mulanje, MalawiE-posterDiagnosis of HIV disease in paediatric and adolescent populations
B57Retention on antiretroviral treatment (ART) six and 18 months after delivery in women living with HIV (WL-HIV), in Brazil, 2010-2017E-posterOther sex- or gender-specific issues
B55Hormonal contraception is associated with increased risk of cardiometabolic disease in women living with HIVE-posterContraception
621 - 630 of 870 items